A PubMed search revealed 1382 articles on pancreatic transplantation, 781 on intestinal transplantation, more than 7200 on kidney transplantation, and more than 5500 on liver transplantation published between January 1, 2018, and December 31, 2018. After narrowing the list down to human studies, 436 pancreatic, 302 intestinal, 1920 liver, and more than 2000 kidney transplantation studies were screened for inclusion in this review.
HuZHGuYJQiuWQet al. Pancreas grafts for transplantation from donors with hypertension: an analysis of the Scientific Registry of Transplant Recipients database. BMC Gastroenterol. 2018;18:141. doi:10.1186/s12876-018-0865-0
2.
BrooksJTLiuROliverMet al. Simultaneous pancreas and kidney transplantation is associated with inferior long-term outcomes in African Americans. Pancreas. 2018;47:116-121. doi:10.1097/MPA.0000000000000958
3.
ZhangRFlormanSParameshAet al. Pancreas transplantation in African American patients using basiliximab induction. Am J Med Sci. 2009;337:307-311. doi:10.1097/MAJ.0b013e31818b0fbe
4.
IsaacsRBNockSLSpencerCEet al. Racial disparities in renal transplant outcomes. Am J Kidney Dis. 1999;34:706-712. doi:10.1016/S0272-6386(99)70397-5
5.
KermanRHKimballPMVan BurenCTLewisRMKahanBD.Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation. 1991;51:338-342.
6.
KandaswamyRStockPGGustafsonSKet al. OPTN/SRTR 2016 Annual Data Report: pancreas. Am J Transplant. 2018;18(suppl 1):114-171. doi:10.1111/ajt.14558
7.
KandaswamyRStockPGGustafsonSKet al. OPTN/SRTR 2015 Annual Data Report: pancreas. Am J Transplant. 2017;17(suppl 1):117-173. doi:10.1111/ajt.14125
8.
TzvetanovIGTullaKAD’AmicoGBenedettiE.Living donor intestinal transplantation. Gastroenterol Clin North Am. 2018;47:369-380. doi:10.1016/j.gtc.2018.01.008
9.
LauroAPanaroFIyerKR.An overview of EU and USA intestinal transplant current activity. J Visc Surg. 2017;154:105-114. doi:10.1016/j.jviscsurg.2017.01.007
10.
SmithJMWeaverTSkeansMAet al. OPTN/SRTR 2016 Annual Data Report: intestine. Am J Transplant. 2018;18(suppl 1):254-290. doi:10.1111/ajt.14560
11.
HartASmithJMSkeansMAet al. OPTN/SRTR 2016 Annual Data Report: kidney. Am J Transplant. 2018;18(suppl 1):18-113. doi:10.1111/ajt.14557
12.
UenoTWadaMHoshinoKet al. Impact of pediatric intestinal transplantation on intestinal failure in Japan: findings based on the Japanese intestinal transplant registry. Pediatr Surg Int. 2013;29:1065-1070. doi:10.1007/s00383-013-3392-7
13.
Garcia ArozSTzvetanovIHettermanEAet al. Long-term outcomes of living-related small intestinal transplantation in children: a single-center experience. Pediatr Transplant. 2017;21(4). doi:10.1111/petr.12910
14.
Calixto FernandesMHSchrickerTMagderSHatzakorzianR.Perioperative fluid management in kidney transplantation: a black box. Crit Care. 2018;22:14. doi:10.1186/s13054-017-1928-2
15.
KapoorHSKaurRKaurH.Anaesthesia for renal transplant surgery. Acta Anaesthesiol Scand. 2007;51:1354-1367. doi:10.1111/j.1399-6576.2007.01447.x
16.
RicaurteLVargasJLozanoEDíazL; Organ Transplant Group. Anesthesia and kidney transplantation. Transplant Proc. 2013;45:1386-1391. doi:10.1016/j.transproceed.2012.12.014
17.
BennettKPaceN.Anaesthesia for renal transplantation: an update. Anesth Intensive Care Med. 2015;17:334-338.
18.
MarikPECavallazziR.Does the central venous pressure predict fluid responsiveness? An updated meta-analysis and a plea for some common sense. Crit Care Med. 2013;41:1774-1781. doi:10.1097/CCM.0b013e31828a25fd
19.
MarxGSchindlerAWMoschCet al. Intravascular volume therapy in adults: guidelines from the Association of the Scientific Medical Societies in Germany. Eur J Anaesthesiol. 2016;33:488-521. doi:10.1097/EJA.0000000000000447
20.
EskesenTGWetterslevMPernerA.Systematic review including re-analyses of 1148 individual data sets of central venous pressure as a predictor of fluid responsiveness. Intensive Care Med. 2016;42:324-332. doi:10.1007/s00134-015-4168-4
21.
SchmidSJungwirthB.Anaesthesia for renal transplant surgery: an update. Eur J Anaesthesiol. 2012;29:552-558. doi:10.1097/EJA.0b013e32835925fc
22.
NagrebetskyADuttonRPEhrenfeldJMUrmanRD.Variation in frequency of intraoperative arterial, central venous and pulmonary artery catheter placement during kidney transplantation: an analysis of invasive monitoring trends. J Med Syst. 2018;42:66. doi:10.1007/s10916-018-0920-y
23.
McGeeDCGouldMK.Preventing complications of central venous catheterization. N Engl J Med. 2003;348:1123-1133. doi:10.1056/NEJMra011883
24.
ChinJHJunIGLeeJSeoHHwangGSKimYK.Can stroke volume variation be an alternative to central venous pressure in patients undergoing kidney transplantation?Transplant Proc. 2014;46:3363-3366. doi:10.1016/j.transproceed.2014.09.097
25.
ToyodaKNinomiyaT.Stroke and cerebrovascular diseases in patients with chronic kidney disease. Lancet Neurol. 2014;13:823-833. doi:10.1016/S1474-4422(14)70026-2
26.
MagderS.Flow-directed vs goal-directed strategy for management of hemodynamics. Curr Opin Crit Care. 2016;22:267-273. doi:10.1097/MCC.0000000000000298
27.
HalawaARoweSRobertsFet al. A better journey for patients, a better deal for the NHS: the successful implementation of an enhanced recovery program after renal transplant surgery. Exp Clin Transplant. 2018;16:127-132. doi:10.6002/ect.2016.0304
28.
PielochDDombrovskiyVOsbandAJet al. The Kidney Transplant Morbidity Index (KTMI): a simple prognostic tool to help determine outcome risk in kidney transplant candidates. Prog Transplant. 2015;25:70-76. doi:10.7182/pit2015462
29.
ParkJYKimMHBaeEJet al. Comorbidities can predict mortality of kidney transplant recipients: com-parison with the Charlson Comorbidity Index. Transplant Proc. 2018;50:1068-1073. doi:10.1016/j.transproceed.2018.01.044
30.
JardineAGGastonRSFellstromBCHoldaasH.Prevention of cardiovascular disease in adult recipients of kidney transplants. Lancet. 2011;378:1419-1427. doi:10.1016/S0140-6736(11)61334-2
31.
IsraniAKSnyderJJSkeansMAet al; PORT Investigators. Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) study. Am J Transplant. 2010;10:338-353. doi:10.1111/j.1600-6143.2009.02949.x
32.
OkumiMKakutaYUnagamiKet al. Cardiovascular disease in kidney transplant recipients: Japan Academic Consortium of Kidney Transplantation (JACK) cohort study. Clin Exp Nephrol. 2018;22:702-709. doi:10.1007/s10157-017-1500-z
33.
XiongYJiangJZhangHet al. Higher renal allograft function in deceased-donor kidney transplantation rather than in living-related kidney transplantation. Transplant Proc. 2018;50:2412-2415. doi:10.1016/j.transproceed.2018.03.041
34.
ZhangHWeiYLiuLet al. Different risk factors for graft survival between living-related and deceased donor kidney transplantation. Transplant Proc. 2018;50:2416-2420. doi:10.1016/j.transproceed.2018.03.047
35.
IsraniAKSalkowskiNGustafsonSet al. New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes. J Am Soc Nephrol. 2014;25:1842-1848. doi:10.1681/ASN.2013070784
36.
TulliusSGRabbH.Improving the supply and quality of deceased-donor organs for transplantation. N Engl J Med. 2018;378:1920-1929. doi:10.1056/NEJMra1507080
37.
SridharSGuzman-ReyesSGumbertSDet al. The new kidney donor allocation system and implications for anesthesiologists. Semin Cardiothorac Vasc Anesth. 2018;22:223-228. doi:10.1177/1089253217728128
38.
ZhuDMcCagueKLinWet al. Outcome of kidney transplantation from donor after cardiac death: reanalysis of the US Mycophenolic Renal Transplant Registry. Transplant Proc. 2018;50:1258-1263. doi:10.1016/j.transproceed.2018.01.051
39.
HartASmithJMSkeansMAet al. OPTN/SRTR 2015 Annual Data Report: kidney. Am J Transplant. 2017;17(suppl 1):21-116. doi:10.1111/ajt.14124
40.
HartAGustafsonSKSkeansMAet al. OPTN/SRTR 2015 Annual Data Report: early effects of the new kidney allocation system. Am J Transplant. 2017;17(suppl 1):543-564.
41.
MoersCSmitsJMMaathuisMHet al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med. 2009;360:7-19. doi:10.1056/NEJMoa0802289
42.
Martínez ArcosLFabuel AlcañizJJGómez Dos SantosVBurgos RevillaFJ. Functional results of renal preservation in hypothermic pulsatile machine perfusion versus cold preservation: systematic review and meta-analysis of clinical trials. Transplant Proc. 2018;50:24-32. doi:10.1016/j.transproceed.2017.12.005
43.
DengRGuGWangDet al. Machine perfusion versus cold storage of kidneys derived from donation after cardiac death: a meta-analysis. PLoS One. 2013;8:e56368. doi:10.1371/journal.pone.0056368
44.
JiaoBLiuSLiuHChengDChengYLiuY.Hypothermic machine perfusion reduces delayed graft function and improves one-year graft survival of kidneys from expanded criteria donors: a meta-analysis. PLoS One. 2013;8:e81826. doi:10.1371/journal.pone.0081826
45.
O’CallaghanJMMorganRDKnightSRMorrisPJ.Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes. Br J Surg. 2013;100:991-1001. doi:10.1002/bjs.9169
46.
KimWRLakeJRSmithJMet al. OPTN/SRTR 2016 Annual Data Report: liver. Am J Transplant. 2018;18(suppl 1):172-253.
47.
VanWagnerLBHarinsteinMERunoJRet al. Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: an evaluation of the evidence and consensus recommendations. Am J Transplant. 2018;18:30-42.
48.
SolderaJCamazzolaFRodríguezSBrandãoA.Cardiac stress testing and coronary artery disease in liver transplantation candidates: meta-analysis. World J Hepatol. 2018;10:877-886.
ParkJLeeSHHanSet al. Elevated high-sensitivity troponin I during living donor liver transplantation is associated with postoperative adverse outcomes. Transplantation. 2018;102:e236-e244.
FlahertyDKimSZerilloJet al. Preoperative QTc interval is not associated with intraoperative cardiac events or mortality in liver transplantation patients. J Cardiothorac Vasc Anesth. 2019;33:961-966. doi:10.1053/j.jvca.2018.06.002
53.
LeeSHParkMParkKMet al. Corrected QT interval on the electrocardiogram after liver transplantation: surrogate marker of poor clinical outcomes?PLoS One. 2018;13:e0206463.
54.
WisénESvennerholmKBownLSet al. Vasopressin and nitroglycerin decrease portal and hepatic venous pressure and hepato-splanchnic blood flow. Acta Anaesthesiol Scand. 2018;62:953-961.
55.
TroisiRIVanlanderAGiglioMCet al. Somatostatin as inflow modulator in liver-transplant recipients with severe portal hypertension: a randomized trial [published online September 21, 2018]. Ann Surg. doi:10.1097/SLA.0000000000003062
56.
ChokesuwattanaskulRThongprayoonCBathiniTet al. Liver transplantation and atrial fibrillation: a meta-analysis. World J Hepatol. 2018;10:761-771.
57.
HuangWADunipaceEASorgJMVaseghiM.Liver disease as a predictor of new-onset atrial fibrillation. J Am Heart Assoc. 2018;7:e008703.
58.
FuHSunKLiJet al. Preoperative beta blockade and severe intraoperative bradycardia in liver transplantation. Clin Transplant. 2018;32:e13422.
ZerilloJHillBKimSDeMariaSJrMandellMS.Use, training, and opinions about effectiveness of transesophageal echocardiography in adult liver transplantation among anesthesiologists in the United States. Semin Cardiothorac Vasc Anesth. 2018;22:137-145.
61.
RoccaroGAGoldbergDSHwangWTet al. Sustained posttransplantation diabetes is associated with long-term major cardiovascular events following liver transplantation. Am J Transplant. 2018;18:207-215.
62.
GiráldezEVaroEGulerIet al. Post-operative stress hyperglycemia is a predictor of mortality in liver transplantation. Diabetol Metab Syndr. 2018;10:35.
63.
PakaPLieberSRLeeRADesaiCSDupuisREBarrittAS.Perioperative glucose management and outcomes in liver transplant recipients: a qualitative systematic review. World J Transplant. 2018;8:75-83.
64.
Ramos-ProlAHervás-MarínDRodríguez-MedinaBet al. Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years. J Endocrinol Invest. 2018;41:821-829.
65.
JunIGKwonHMJungKWet al. The impact of postreperfusion syndrome on acute kidney injury in living donor liver transplantation: a propensity score analysis. Anesth Analg. 2018;127:369-378.
66.
Skytte LarssonJBragadottirGRedforsBRickstenSE. Renal effects of norepinephrine-induced variations in mean arterial pressure after liver transplantation: a randomized cross-over trial. Acta Anaesthesiol Scand. 2018;62:1229-1236.
67.
KwonHMMoonYJJungKWet al. Low mean arterial blood pressure is independently associated with postoperative acute kidney injury after living donor liver transplantation: a propensity score weighing analysis. Ann Transplant. 2018;23:236-245.
68.
CodesLde SouzaYGD’OliveiraRACBastosJLABittencourtPL. Cumulative positive fluid balance is a risk factor for acute kidney injury and requirement for renal replacement therapy after liver transplantation. World J Transplant. 2018;8:44-51.
69.
KimWHLeeHCLimLRyuHGJungCW.Intraoperative oliguria with decreased SvO2 predicts acute kidney injury after living donor liver transplantation. J Clin Med. 2018;8:E29.
70.
CullaroGPisaJFBrownRSJrWagenerGVernaEC.Early postoperative neutrophil gelatinase-associated lipocalin predicts the development of chronic kidney disease after liver transplantation. Transplantation. 2018;102:809-815.
71.
ChaeMSParkHChoiHJet al. Role of serum levels of intraoperative brain natriuretic peptide for predicting acute kidney injury in living donor liver transplantation. PLoS One. 2018;13:e0209164.
72.
PulitanoCHoPVerranDet al. Molecular profiling of postreperfusion milieu determines acute kidney injury after liver transplantation: a prospective study. Liver Transpl. 2018;24:922-931.
73.
AdelmannDOlmosALiuLLet al. Intraoperative management of liver transplant patients without the routine use of renal replacement therapy. Transplantation. 2018;102:e229-e235.
74.
MassicotteLCarrierFMDenaultAYet al. Development of a predictive model for blood transfusions and bleeding during liver transplantation: an observational cohort study. J Cardiothorac Vasc Anesth. 2018;32:1722-1730.
PaganoMBMetcalfRAHessJRReyesJPerkinsJDMontenovoMI.A high plasma: red blood cell transfusion ratio during liver transplantation is associated with decreased blood utilization. Vox Sang. 2018;113:268-274.
77.
SrivastavaPAgarwalAJhaAet al. Utility of prothrombin complex concentrate as first-line treatment modality of coagulopathy in patients undergoing liver transplantation: a propensity score-matched study. Clin Transplant. 2018;32:e13435.
78.
WangYLiQMaTet al. Transfusion of older red blood cells increases the risk of acute kidney injury after orthotopic liver transplantation: a propensity score analysis. Anesth Analg. 2018;127:202-209.
79.
HanSKwonJHJungSHet al. Perioperative fresh red blood cell transfusion may negatively affect recipient survival after liver transplantation. Ann Surg. 2018;267:346-351.
80.
FukazawaKPrettoEAJrNishidaSReyesJDGologorskyE.Factors associated with mortality within 24h of liver transplantation: an updated analysis of 65,308 adult liver transplant recipients between 2002 and 2013. J Clin Anesth. 2018;44:35-40.
81.
MandellDPlaninsicRMeleanFet al. Critical importance of low-dose tissue plasminogen activator policy for treating intraoperative pulmonary thromboembolism during liver transplantation. Semin Cardiothorac Vasc Anesth. 2018;22:376-382.
82.
von MeijenfeldtFABurlageLCBosSAdelmeijerJPorteRJLismanT.Elevated plasma levels of cell-free DNA during liver transplantation are associated with activation of coagulation. Liver Transpl. 2018;24:1716-1725.
83.
MoharemHAFetouhFADarwishHMet al. Effects of bacterial translocation on hemodynamic and coagulation parameters during living-donor liver transplant. BMC Anesthesiol. 2018;18:46.
84.
HarriesLGwiasdaJQuZSchremHKrauthCAmelungVE. Potential savings in the treatment pathway of liver transplantation: an inter-sectorial analysis of cost-rising factors [published online July 26, 2018]. Eur J Health Econ. doi:10.1007/s10198-018-0994-y
85.
BhutianiNJonesCMCannonRMet al. Assessing relative cost of complications following orthotopic liver transplant. Clin Transplant. 2018;32:e13209.
86.
RuizJDuganADavenportDLGedalyR.Blood transfusion is a critical determinant of resource utilization and total hospital cost in liver transplantation. Clin Transplant. 2018;32(2). doi:10.1111/ctr.13164
87.
NedelcuEWrightMFKarpSCookMBarbuOEichbaumQ.Quality improvement in transfusion practice of orthotopic liver transplantation reduces blood utilization, length of hospital stay, and cost. Am J Clin Pathol. 2019;151:395-402. doi:10.1093/ajcp/aqy154
88.
Leon-JustelAAlvarez-RiosAINoval-PadilloJAet al. Point-of-care haemostasis monitoring during liver transplantation is cost effective [published online December 11, 2018]. Clin Chem Lab Med. doi:10.1515/cclm-2018-0889
89.
BiancofioreGTomescuDRMandellMS.Rapid recovery of liver transplantation recipients by implementation of fast-track care steps: what is holding us back?Semin Cardiothorac Vasc Anesth. 2018;22:191-196.
90.
LiJWangCJiangYet al. Immediate versus conventional postoperative tracheal extubation for enhanced recovery after liver transplantation: IPTE versus CTE for enhanced recovery after liver transplantation. Medicine (Baltimore). 2018;97:e13082.
91.
BrustiaRMonselAContiFet al. Enhanced recovery in liver transplantation: a feasibility study. World J Surg. 2019;43:230-241. doi:10.1007/s00268-018-4747-y
92.
Abu-GazalaSOlthoffKM.Status of adult living donor liver transplantation in the United States: results from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Gastroenterol Clin North Am. 2018;47:297-311.
93.
ButtZDiMartiniAFLiuQet al. Fatigue, pain, and other physical symptoms of living liver donors in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study. Liver Transpl. 2018;24:1221-1232.
94.
ShirabeKEguchiSOkajimaHet al; Japanese Liver Transplantation Society. Current status of surgical incisions used in donors during living related liver transplantation—a nationwide survey in Japan. Transplantation. 2018;102:1293-1299.
95.
BroeringDCElsheikhYShagraniMAbaalkhailFTroisiRI.Pure laparoscopic living donor left lateral sectionectomy in pediatric transplantation: a propensity score analysis on 220 consecutive patients. Liver Transpl. 2018;24:1019-1030.
96.
SuhKSHongSKLeeKWet al. Pure laparoscopic living donor hepatectomy: focus on 55 donors undergoing right hepatectomy. Am J Transplant. 2018;18:434-443.
97.
AuKPChokKSH.Minimally invasive donor hepatectomy, are we ready for prime time?World J Gastroenterol. 2018Jul7;24(25):2698-2709.
